Stocosil Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 15
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $2.03M
Latest Deal Amount

Stocosil General Information


Developer of anti-hypertension drugs. The company specializes in developing personalized dosing for anti-hypertension.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Services
Drug Delivery
Primary Office
  • 17870 Castleton Street
  • Suite 250
  • Industry, CA 91748
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Stocosil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 12-Jul-2016 $2.03M 00.000 Completed Startup
To view Stocosil’s complete valuation and funding history, request access »

Stocosil Executive Team (3)

Name Title Board Seat Contact Info
Pyng Soon Chief Executive Officer, Chief Financial Officer & Secretary
Vuong Trieu Ph.D Chairman & Chief Regulatory Officer
Chulho Park Ph.D Chief Business Officer
To view Stocosil’s complete executive team members history, request access »

Stocosil Board Members (1)

Name Representing Role Since
Vuong Trieu Ph.D Self Chairman & Chief Regulatory Officer 000 0000
To view Stocosil’s complete board members history, request access »

Stocosil Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial